GWA
ABBV icon

Genesis Wealth Advisors’s AbbVie ABBV Stock Holding History

Genesis Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$87.3K Hold
1,300
– – 0.07% 132
2015
Q1 		$74.2K Hold
1,300
– – 0.06% 158
2014
Q4 		$78.8K Buy
+1,300
New +$82K 0.06% 165

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Genesis Wealth Advisors's ABBV Position: Q2 2015 in Review

Genesis Wealth Advisors held its AbbVie (ABBV) position steady in Q2 2015 at 1,300 shares worth $87.3K. The position accounts for 0.07% of the portfolio, ranked #132.

Genesis Wealth Advisors first reported a position in ABBV in Q4 2014 and has held it in 3 quarters since. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Genesis Wealth Advisors held 1,300 shares of AbbVie worth $87.3K as of Q2 2015.
  • Genesis Wealth Advisors left its AbbVie share count unchanged in Q2 2015.
  • AbbVie made up 0.07% of Genesis Wealth Advisors's portfolio in Q2 2015, its #132 holding.
  • Genesis Wealth Advisors first reported a position in AbbVie in Q4 2014 and has held it in 3 quarters since.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Genesis Wealth Advisors's 13F filing for Q2 2015, filed 24 Aug 2015.